Key Financial Inc Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Key Financial Inc raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,166 shares of the exchange traded fund’s stock after purchasing an additional 400 shares during the period. Key Financial Inc’s holdings in SPDR S&P Biotech ETF were worth $105,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $141,284,000. Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after acquiring an additional 588,489 shares during the period. Sivik Global Healthcare LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $29,640,000. Finally, Mirae Asset Securities USA Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after acquiring an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1 %

NYSEARCA XBI opened at $91.33 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The business’s fifty day simple moving average is $91.51 and its 200-day simple moving average is $96.03. The firm has a market cap of $6.96 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.